Medicare Part D coverage · estradiol cypionate · RxCUI 206417
estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol]
Per the CMS 2026 Part D formulary file, estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] is covered by 2,205 Medicare Part D plans (43.6% of enrollable products), averaging Tier 3.5, with prior authorization required on 0% of covering formularies.
- 43.6%
- Plan coverage
- 2,205
- Plans covering
- T3.5
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol]
Per the CMS 2026 Part D formulary file, estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] (RxNorm concept RXCUI 206417, generic name estradiol cypionate) appears on 59 distinct formulary files spanning 2,205 Medicare Part D plan offerings - 43.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,893 Part D beneficiaries filled estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] in 2023, with total plan-and-beneficiary spending of $681,218 and an average per-beneficiary annual cost of $359.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] today.
Coverage Details
- Formularies covering
- 59
- Plans covering
- 2,205
- Coverage rate
- 43.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,893
- Total spending
- $681,218
- Avg per beneficiary
- $359.86
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] covered by Medicare Part D?
Yes, estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] is covered by 2,205 Medicare Part D plans (43.6% of all Part D formularies).
What tier is estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] on Medicare Part D plans?
estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] require prior authorization?
0% of Part D formularies require prior authorization for estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol]?
In 2023, total Medicare Part D spending on estradiol cypionate 5 MG/ML Injectable Solution [Depo-estradiol] was $681,218, covering 1,893 beneficiaries. The average spend per beneficiary was $359.86.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 90 DAY estradiol 0.000313 MG/HR Vaginal System [Estring] T3.5
- bromocriptine 0.8 MG Oral Tablet [Cycloset] T3.5
- 8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule [Rytary] T3.5
- tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobrex] T3.5
- lomustine 40 MG Oral Capsule [Gleostine] T3.6
- isotretinoin 35 MG Oral Capsule T3.6